We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Celadon Pharmaceuticals Plc | LSE:CEL | London | Ordinary Share | GB00BDQYGP38 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 1.50 | 1.50% | 101.50 | 98.00 | 105.00 | 101.50 | 101.50 | 101.50 | 722 | 08:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Investment Advice | 24k | -17.01M | -0.2722 | -3.73 | 63.41M |
From May 2019 to May 2024
TIDMSWC
RNS Number : 3928E
Summerway Capital PLC
27 February 2020
27 February 2020
Summerway Capital plc
("Summerway" or the "Company")
Results of Annual General Meeting
Following the Annual General Meeting of the Company, which was held earlier today, the Board is pleased to announce that all ordinary and special resolutions set out in the Notice of Annual General Meeting were duly passed.
Details of the number of proxy votes cast for, against and withheld on the resolutions will be published on the Company's website at https://www.summerwaycapital.co.uk/rns .
Enquiries:
Summerway Capital Mark Farmiloe 020 7440 7520 N+1 Singer (Nominated Adviser and Broker) Sandy Fraser / Lauren Kettle 020 7496 3000
END
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
RAGTRMITMTJTBLM
(END) Dow Jones Newswires
February 27, 2020 10:00 ET (15:00 GMT)
1 Year Celadon Pharmaceuticals Chart |
1 Month Celadon Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
